| RS1601738571 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1601738999 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1601739229 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1601739478 |
HMOX1
|
Health Risk |
Likely pathogenic |
— |
| RS1601747985 |
PHKA2
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXa1, Thyroid cancer |
| RS1601748137 |
STS
|
Health Risk |
Pathogenic |
X-linked ichthyosis with steryl-sulfatase deficiency, X-linked ichthyosis with steryl-sulfatase deficiency |
| RS1601748177 |
PHKA2
|
Health Risk |
Likely pathogenic |
PHKA2-related disorder, PHKA2-related disorder |
| RS1601748216 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1601752050 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1601752066 |
CHEK2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1601753141 |
CHEK2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1601755632 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Epilepsy, familial focal |
| RS1601760689 |
PHKA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IXa1, Increased hepatic glycogen content |
| RS1601761445 |
GLRA2
|
Health Risk |
Pathogenic |
See cases, Intellectual developmental disorder |
| RS1601763099 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1601769604 |
MSL3
|
Health Risk |
Pathogenic |
Global developmental delay, Basilicata-Akhtar syndrome |
| RS1601769873 |
MSL3
|
Health Risk |
Pathogenic |
— |
| RS1601774648 |
MSL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Basilicata-Akhtar syndrome, Basilicata-Akhtar syndrome |
| RS1601776276 |
PHKA2
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1601776523 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1601777275 |
CHEK2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1601779091 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS1601780766 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1601781024 |
PHKA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1601781031 |
PHKA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1601782720 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Familial cancer of breast |
| RS1601783375 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1601783879 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1601784008 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1601792367 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS1601795448 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS1601803431 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS1601805361 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1601805632 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1601808175 |
DMD
|
Health Risk |
Likely pathogenic |
— |
| RS1601808288 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1601808296 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1601808326 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1601808412 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1601808608 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1601808932 |
DMD
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dystrophin, Duchenne muscular dystrophy |
| RS1601809011 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS1601810456 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1601810667 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1601814238 |
PDXK
|
Health Risk |
Likely pathogenic |
Neuropathy, hereditary motor and sensory |
| RS1601822717 |
CHEK2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1601822722 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1601823008 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1601823036 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1601823546 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1601824130 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1601824270 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1601825425 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1601825829 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1601838818 |
NHS
|
Health Risk |
Likely pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS1601842249 |
MB
|
Health Risk |
Pathogenic/Likely pathogenic |
Myopathy, sarcoplasmic body |
| RS1601844140 |
TBL1X
|
Health Risk |
Likely pathogenic |
Hypothyroidism, congenital |
| RS1601851066 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1601851248 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1601851716 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1601851875 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1601852451 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1601853112 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1601853585 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1601855887 |
CSTB
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS1601856142 |
ADGRG2
|
Health Risk |
Pathogenic |
Congenital bilateral aplasia of vas deferens from CFTR mutation, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS1601859570 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS1601861196 |
IFNAR1
|
Health Risk |
risk factor |
Immunodeficiency 106, susceptibility to viral infections |
| RS1601861199 |
IFNAR1
|
Health Risk |
risk factor |
Immunodeficiency 106, susceptibility to viral infections |
| RS1601862802 |
ADGRG2
|
Health Risk |
Pathogenic |
Congenital bilateral aplasia of vas deferens from CFTR mutation, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS1601864055 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1601871234 |
ADGRG2
|
Health Risk |
Pathogenic |
Congenital bilateral aplasia of vas deferens from CFTR mutation, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS1601875057 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS1601878540 |
SOX10
|
Health Risk |
Pathogenic/Likely pathogenic |
Waardenburg syndrome type 2E, PCWH syndrome |
| RS1601878759 |
SOX10
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1601880424 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS1601882239 |
SOX10
|
Health Risk |
Likely pathogenic |
— |
| RS1601886662 |
SOX10
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 2E, Inborn genetic diseases |
| RS1601887036 |
SOX10
|
Health Risk |
Pathogenic |
Hypogonadism with anosmia, Hypogonadism with anosmia |
| RS1601888330 |
ADGRG2
|
Health Risk |
Pathogenic |
Congenital bilateral aplasia of vas deferens from CFTR mutation, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS1601890980 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601891936 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601891967 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601892395 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601910946 |
GK
|
Health Risk |
Likely pathogenic |
— |
| RS1601914175 |
PTCHD1
|
Health Risk |
Pathogenic |
— |
| RS1601917052 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1601917999 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1601918140 |
RPGR
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1601918200 |
PTCHD1
|
Health Risk |
Likely pathogenic |
— |
| RS1601919915 |
RPGR
|
Health Risk |
Pathogenic |
— |
| RS1601919951 |
RPGR
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1601920131 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 3, Retinitis pigmentosa |
| RS1601920423 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 3 |
| RS1601920532 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 3 |
| RS1601920599 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601922074 |
RPGR
|
Health Risk |
Pathogenic |
— |
| RS1601922202 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Primary ciliary dyskinesia |
| RS1601922510 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 3, Retinitis pigmentosa 3 |
| RS1601922877 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |